z-logo
open-access-imgOpen Access
Polymorphic locus rs1061624 of the ТNFR2 gene is associated with the development of arterial hypertension in males
Author(s) -
Maria Moskalenko,
Irina Ponomarenko,
С Н Миланова,
I.N. Verzilina,
О. А. Ефремова,
Alexey Polonikov
Publication year - 2020
Publication title -
kardiologiâ
Language(s) - English
Resource type - Journals
eISSN - 2412-5660
pISSN - 0022-9040
DOI - 10.18087/cardio.2020.8.n996
Subject(s) - locus (genetics) , confidence interval , gene , promoter , microbiology and biotechnology , enhancer , genetics , polymerase chain reaction , biology , medicine , gene expression
Aim To study the involvement of cytokine polymorphous loci in development of arterial hypertension (AH) in men from the Central Black Earth region of Russia.Materials and methods 821 men were evaluated, including 564 patients with AH and 257 individuals of the control group. Analysis of 8 cytokine mononucleotide polymorphisms (MNP) was performed using the real-time polymerase chain reaction with TagMan probes. Statistical analysis was performed with the STATISTICA (v.10.0) and PLINK (v.1.06) software. The regulatory potential of MNP was analyzed with the HaploReg (v.4.1) service (http://archive.broadinstitute.org).Results The rs1061624 ТNFR2 polymorphous locus was associated with development of AH in men in recessive (odd ratio (OR), 0.33; 95 % confidence interval (CI): 0.18-0.61, рperm=0.0004) and additive (OR, 0.50, 95 % CI: 0.34-0.74, рperm=0.0006) genetic models and exerted a protective effect in development of AH. The rs1061624 MNP of the ТNFR2 gene has a regulatory significance; it is located in the DNA sites hypersensitive to the action of DNAase 1 and in binding sites for transcriptional factors and histones that mark enhancers and promoters in different organs and tissues.Conclusion The rs1061624 ТNFR2 gene polymorphism is involved in the development of AH in men of the Central Black Earth region of Russia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here